Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Androstenedione Market 2018, Forecast to 2023

Publisher Name :
Date: 21-Jun-2018
No. of pages: 148

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) - an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.

Scope of the Report:

This report focuses on the Androstenedione in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.

Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

The worldwide market for Androstenedione is expected to grow at a CAGR of roughly 0.8% over the next five years, will reach 200 million US$ in 2023, from 190 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

- BIOVET

- Indo Phyto Chemicals

- Sito Bio

- Goto Pharmaceutical

- Tianjin King York

- Jiufu

- Yongning Pharma

- Jiangxi Hongyuan Pharmaceutical

- Kaizon

- Xi'an Gaoyuan Bio-Chem

- Dongyao Pharmaceutical

- Huazhong Pharmaceutical

- Darui

- Danjiangkou Danao

- Dahua Pharmaceutical

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia etc.)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

- 4-AD

- ADD

Market Segment by Applications, can be divided into

- Arthritis Pharmaceuticals

- Fertility Control Pharmaceuticals

- Infectious Inflammation Pharmaceuticals

- Others

There are 15 Chapters to deeply display the global Androstenedione market.

Chapter 1, to describe Androstenedione Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Androstenedione, with sales, revenue, and price of Androstenedione, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Androstenedione, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Androstenedione market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Androstenedione sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Androstenedione Market 2018, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Androstenedione Introduction
1.2 Market Analysis by Type
1.2.1 4-AD
1.2.2 ADD
1.3 Market Analysis by Applications
1.3.1 Arthritis Pharmaceuticals
1.3.2 Fertility Control Pharmaceuticals
1.3.3 Infectious Inflammation Pharmaceuticals
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 BIOVET
2.1.1 Business Overview
2.1.1.1 BIOVET Description
2.1.1.2 BIOVET Headquarter, Main Business and Finance Overview
2.1.2 BIOVET Androstenedione Product Introduction
2.1.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.1.2.2 Androstenedione Product Information
2.1.3 BIOVET Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 BIOVET Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global BIOVET Androstenedione Market Share in 2017
2.2 Indo Phyto Chemicals
2.2.1 Business Overview
2.2.1.1 Indo Phyto Chemicals Description
2.2.1.2 Indo Phyto Chemicals Headquarter, Main Business and Finance Overview
2.2.2 Indo Phyto Chemicals Androstenedione Product Introduction
2.2.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.2.2.2 Androstenedione Product Information
2.2.3 Indo Phyto Chemicals Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Indo Phyto Chemicals Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Indo Phyto Chemicals Androstenedione Market Share in 2017
2.3 Sito Bio
2.3.1 Business Overview
2.3.1.1 Sito Bio Description
2.3.1.2 Sito Bio Headquarter, Main Business and Finance Overview
2.3.2 Sito Bio Androstenedione Product Introduction
2.3.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.3.2.2 Androstenedione Product Information
2.3.3 Sito Bio Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Sito Bio Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Sito Bio Androstenedione Market Share in 2017
2.4 Goto Pharmaceutical
2.4.1 Business Overview
2.4.1.1 Goto Pharmaceutical Description
2.4.1.2 Goto Pharmaceutical Headquarter, Main Business and Finance Overview
2.4.2 Goto Pharmaceutical Androstenedione Product Introduction
2.4.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.4.2.2 Androstenedione Product Information
2.4.3 Goto Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Goto Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Goto Pharmaceutical Androstenedione Market Share in 2017
2.5 Tianjin King York
2.5.1 Business Overview
2.5.1.1 Tianjin King York Description
2.5.1.2 Tianjin King York Headquarter, Main Business and Finance Overview
2.5.2 Tianjin King York Androstenedione Product Introduction
2.5.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.5.2.2 Androstenedione Product Information
2.5.3 Tianjin King York Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Tianjin King York Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Tianjin King York Androstenedione Market Share in 2017
2.6 Jiufu
2.6.1 Business Overview
2.6.1.1 Jiufu Description
2.6.1.2 Jiufu Headquarter, Main Business and Finance Overview
2.6.2 Jiufu Androstenedione Product Introduction
2.6.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.6.2.2 Androstenedione Product Information
2.6.3 Jiufu Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 Jiufu Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global Jiufu Androstenedione Market Share in 2017
2.7 Yongning Pharma
2.7.1 Business Overview
2.7.1.1 Yongning Pharma Description
2.7.1.2 Yongning Pharma Headquarter, Main Business and Finance Overview
2.7.2 Yongning Pharma Androstenedione Product Introduction
2.7.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.7.2.2 Androstenedione Product Information
2.7.3 Yongning Pharma Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.1 Yongning Pharma Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.3.2 Global Yongning Pharma Androstenedione Market Share in 2017
2.8 Jiangxi Hongyuan Pharmaceutical
2.8.1 Business Overview
2.8.1.1 Jiangxi Hongyuan Pharmaceutical Description
2.8.1.2 Jiangxi Hongyuan Pharmaceutical Headquarter, Main Business and Finance Overview
2.8.2 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Introduction
2.8.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.8.2.2 Androstenedione Product Information
2.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.1 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.3.2 Global Jiangxi Hongyuan Pharmaceutical Androstenedione Market Share in 2017
2.9 Kaizon
2.9.1 Business Overview
2.9.1.1 Kaizon Description
2.9.1.2 Kaizon Headquarter, Main Business and Finance Overview
2.9.2 Kaizon Androstenedione Product Introduction
2.9.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.9.2.2 Androstenedione Product Information
2.9.3 Kaizon Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.1 Kaizon Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.3.2 Global Kaizon Androstenedione Market Share in 2017
2.10 Xi'an Gaoyuan Bio-Chem
2.10.1 Business Overview
2.10.1.1 Xi'an Gaoyuan Bio-Chem Description
2.10.1.2 Xi'an Gaoyuan Bio-Chem Headquarter, Main Business and Finance Overview
2.10.2 Xi'an Gaoyuan Bio-Chem Androstenedione Product Introduction
2.10.2.1 Androstenedione Production Bases, Sales Regions and Major Competitors
2.10.2.2 Androstenedione Product Information
2.10.3 Xi'an Gaoyuan Bio-Chem Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.1 Xi'an Gaoyuan Bio-Chem Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10.3.2 Global Xi'an Gaoyuan Bio-Chem Androstenedione Market Share in 2017
2.11 Dongyao Pharmaceutical
2.11.1 Business Overview
2.11.2 Dongyao Pharmaceutical Androstenedione Product Introduction
2.11.3 Dongyao Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Huazhong Pharmaceutical
2.12.1 Business Overview
2.12.2 Huazhong Pharmaceutical Androstenedione Product Introduction
2.12.3 Huazhong Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Darui
2.13.1 Business Overview
2.13.2 Darui Androstenedione Product Introduction
2.13.3 Darui Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Danjiangkou Danao
2.14.1 Business Overview
2.14.2 Danjiangkou Danao Androstenedione Product Introduction
2.14.3 Danjiangkou Danao Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Dahua Pharmaceutical
2.15.1 Business Overview
2.15.2 Dahua Pharmaceutical Androstenedione Product Introduction
2.15.3 Dahua Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Androstenedione Market Competition, by Manufacturer
3.1 Global Androstenedione Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Androstenedione Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Androstenedione Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Androstenedione Manufacturer Market Share in 2017
3.4.2 Top 5 Androstenedione Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Androstenedione Market Analysis by Regions
4.1 Global Androstenedione Sales, Revenue and Market Share by Regions
4.1.1 Global Androstenedione Sales by Regions (2013-2018)
4.1.2 Global Androstenedione Revenue by Regions (2013-2018)
4.2 North America Androstenedione Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Androstenedione Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Androstenedione Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Androstenedione Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Androstenedione Sales, Revenue and Growth Rate (2013-2018)
5 North America Androstenedione by Countries, Type, Application and Manufacturers
5.1 North America Androstenedione Sales, Revenue and Market Share by Countries
5.1.1 North America Androstenedione Sales by Countries (2013-2018)
5.1.2 North America Androstenedione Revenue by Countries (2013-2018)
5.1.3 United States Androstenedione Sales and Growth Rate (2013-2018)
5.1.4 Canada Androstenedione Sales and Growth Rate (2013-2018)
5.1.5 Mexico Androstenedione Sales and Growth Rate (2013-2018)
5.2 North America Androstenedione Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Androstenedione Sales by Manufacturers (2016-2017)
5.2.2 North America Androstenedione Revenue by Manufacturers (2016-2017)
5.3 North America Androstenedione Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Androstenedione Sales and Sales Share by Type (2013-2018)
5.3.2 North America Androstenedione Revenue and Revenue Share by Type (2013-2018)
5.4 North America Androstenedione Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Androstenedione Sales and Sales Share by Application (2013-2018)
5.4.2 North America Androstenedione Revenue and Revenue Share by Application (2013-2018)
6 Europe Androstenedione by Countries, Type, Application and Manufacturers
6.1 Europe Androstenedione Sales, Revenue and Market Share by Countries
6.1.1 Europe Androstenedione Sales by Countries (2013-2018)
6.1.2 Europe Androstenedione Revenue by Countries (2013-2018)
6.1.3 Germany Androstenedione Sales and Growth Rate (2013-2018)
6.1.4 UK Androstenedione Sales and Growth Rate (2013-2018)
6.1.5 France Androstenedione Sales and Growth Rate (2013-2018)
6.1.6 Russia Androstenedione Sales and Growth Rate (2013-2018)
6.1.7 Italy Androstenedione Sales and Growth Rate (2013-2018)
6.2 Europe Androstenedione Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Androstenedione Sales by Manufacturers (2016-2017)
6.2.2 Europe Androstenedione Revenue by Manufacturers (2016-2017)
6.3 Europe Androstenedione Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Androstenedione Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Androstenedione Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Androstenedione Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Androstenedione Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Androstenedione Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Androstenedione by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Androstenedione Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Androstenedione Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Androstenedione Revenue by Countries (2013-2018)
7.1.3 China Androstenedione Sales and Growth Rate (2013-2018)
7.1.4 Japan Androstenedione Sales and Growth Rate (2013-2018)
7.1.5 Korea Androstenedione Sales and Growth Rate (2013-2018)
7.1.6 India Androstenedione Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Androstenedione Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Androstenedione Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Androstenedione Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Androstenedione Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Androstenedione Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Androstenedione Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Androstenedione Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Androstenedione Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Androstenedione Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Androstenedione Revenue and Revenue Share by Application (2013-2018)
8 South America Androstenedione by Countries, Type, Application and Manufacturers
8.1 South America Androstenedione Sales, Revenue and Market Share by Countries
8.1.1 South America Androstenedione Sales by Countries (2013-2018)
8.1.2 South America Androstenedione Revenue by Countries (2013-2018)
8.1.3 Brazil Androstenedione Sales and Growth Rate (2013-2018)
8.1.4 Argentina Androstenedione Sales and Growth Rate (2013-2018)
8.1.5 Colombia Androstenedione Sales and Growth Rate (2013-2018)
8.2 South America Androstenedione Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Androstenedione Sales by Manufacturers (2016-2017)
8.2.2 South America Androstenedione Revenue by Manufacturers (2016-2017)
8.3 South America Androstenedione Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Androstenedione Sales and Sales Share by Type (2013-2018)
8.3.2 South America Androstenedione Revenue and Revenue Share by Type (2013-2018)
8.4 South America Androstenedione Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Androstenedione Sales and Sales Share by Application (2013-2018)
8.4.2 South America Androstenedione Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Androstenedione by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Androstenedione Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Androstenedione Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Androstenedione Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Androstenedione Sales and Growth Rate (2013-2018)
9.1.4 UAE Androstenedione Sales and Growth Rate (2013-2018)
9.1.5 Egypt Androstenedione Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Androstenedione Sales and Growth Rate (2013-2018)
9.1.7 South Africa Androstenedione Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Androstenedione Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Androstenedione Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Androstenedione Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Androstenedione Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Androstenedione Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Androstenedione Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Androstenedione Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Androstenedione Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Androstenedione Revenue and Revenue Share by Application (2013-2018)
10 Global Androstenedione Market Segment by Type
10.1 Global Androstenedione Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Androstenedione Sales and Market Share by Type (2013-2018)
10.1.2 Global Androstenedione Revenue and Market Share by Type (2013-2018)
10.2 4-AD Sales Growth and Price
10.2.1 Global 4-AD Sales Growth (2013-2018)
10.2.2 Global 4-AD Price (2013-2018)
10.3 ADD Sales Growth and Price
10.3.1 Global ADD Sales Growth (2013-2018)
10.3.2 Global ADD Price (2013-2018)
11 Global Androstenedione Market Segment by Application
11.1 Global Androstenedione Sales Market Share by Application (2013-2018)
11.2 Arthritis Pharmaceuticals Sales Growth (2013-2018)
11.3 Fertility Control Pharmaceuticals Sales Growth (2013-2018)
11.4 Infectious Inflammation Pharmaceuticals Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Androstenedione Market Forecast (2018-2023)
12.1 Global Androstenedione Sales, Revenue and Growth Rate (2018-2023)
12.2 Androstenedione Market Forecast by Regions (2018-2023)
12.2.1 North America Androstenedione Market Forecast (2018-2023)
12.2.2 Europe Androstenedione Market Forecast (2018-2023)
12.2.3 Asia-Pacific Androstenedione Market Forecast (2018-2023)
12.2.4 South America Androstenedione Market Forecast (2018-2023)
12.2.5 Middle East and Africa Androstenedione Market Forecast (2018-2023)
12.3 Androstenedione Market Forecast by Type (2018-2023)
12.3.1 Global Androstenedione Sales Forecast by Type (2018-2023)
12.3.2 Global Androstenedione Market Share Forecast by Type (2018-2023)
12.4 Androstenedione Market Forecast by Application (2018-2023)
12.4.1 Global Androstenedione Sales Forecast by Application (2018-2023)
12.4.2 Global Androstenedione Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Androstenedione Picture
Table Product Specifications of Androstenedione
Figure Global Androstenedione CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Androstenedione CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Androstenedione by Types in 2017
Figure 4-AD Picture
Table Major Manufacturers of 4-AD
Figure ADD Picture
Table Major Manufacturers of ADD
Figure Androstenedione Sales Market Share by Applications in 2017
Figure Arthritis Pharmaceuticals Picture
Figure Fertility Control Pharmaceuticals Picture
Figure Infectious Inflammation Pharmaceuticals Picture
Figure Others Picture
Figure United States Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure France Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure UK Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure China Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure India Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Androstenedione Revenue (Value) and Growth Rate (2013-2023)
Table BIOVET Headquarter, Established, Main Business and Finance Overview (2017)
Table BIOVET Androstenedione Production Bases, Sales Regions and Major Competitors
Table BIOVET Androstenedione Product
Table BIOVET Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global BIOVET Androstenedione Sales Market Share in 2017
Figure Global BIOVET Androstenedione Revenue Market Share in 2017
Table Indo Phyto Chemicals Headquarter, Established, Main Business and Finance Overview (2017)
Table Indo Phyto Chemicals Androstenedione Production Bases, Sales Regions and Major Competitors
Table Indo Phyto Chemicals Androstenedione Product
Table Indo Phyto Chemicals Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Indo Phyto Chemicals Androstenedione Sales Market Share in 2017
Figure Global Indo Phyto Chemicals Androstenedione Revenue Market Share in 2017
Table Sito Bio Headquarter, Established, Main Business and Finance Overview (2017)
Table Sito Bio Androstenedione Production Bases, Sales Regions and Major Competitors
Table Sito Bio Androstenedione Product
Table Sito Bio Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sito Bio Androstenedione Sales Market Share in 2017
Figure Global Sito Bio Androstenedione Revenue Market Share in 2017
Table Goto Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Goto Pharmaceutical Androstenedione Production Bases, Sales Regions and Major Competitors
Table Goto Pharmaceutical Androstenedione Product
Table Goto Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Goto Pharmaceutical Androstenedione Sales Market Share in 2017
Figure Global Goto Pharmaceutical Androstenedione Revenue Market Share in 2017
Table Tianjin King York Headquarter, Established, Main Business and Finance Overview (2017)
Table Tianjin King York Androstenedione Production Bases, Sales Regions and Major Competitors
Table Tianjin King York Androstenedione Product
Table Tianjin King York Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Tianjin King York Androstenedione Sales Market Share in 2017
Figure Global Tianjin King York Androstenedione Revenue Market Share in 2017
Table Jiufu Headquarter, Established, Main Business and Finance Overview (2017)
Table Jiufu Androstenedione Production Bases, Sales Regions and Major Competitors
Table Jiufu Androstenedione Product
Table Jiufu Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Jiufu Androstenedione Sales Market Share in 2017
Figure Global Jiufu Androstenedione Revenue Market Share in 2017
Table Yongning Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Yongning Pharma Androstenedione Production Bases, Sales Regions and Major Competitors
Table Yongning Pharma Androstenedione Product
Table Yongning Pharma Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Yongning Pharma Androstenedione Sales Market Share in 2017
Figure Global Yongning Pharma Androstenedione Revenue Market Share in 2017
Table Jiangxi Hongyuan Pharmaceutical Headquarter, Established, Main Business and Finance Overview (2017)
Table Jiangxi Hongyuan Pharmaceutical Androstenedione Production Bases, Sales Regions and Major Competitors
Table Jiangxi Hongyuan Pharmaceutical Androstenedione Product
Table Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Jiangxi Hongyuan Pharmaceutical Androstenedione Sales Market Share in 2017
Figure Global Jiangxi Hongyuan Pharmaceutical Androstenedione Revenue Market Share in 2017
Table Kaizon Headquarter, Established, Main Business and Finance Overview (2017)
Table Kaizon Androstenedione Production Bases, Sales Regions and Major Competitors
Table Kaizon Androstenedione Product
Table Kaizon Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Kaizon Androstenedione Sales Market Share in 2017
Figure Global Kaizon Androstenedione Revenue Market Share in 2017
Table Xi'an Gaoyuan Bio-Chem Headquarter, Established, Main Business and Finance Overview (2017)
Table Xi'an Gaoyuan Bio-Chem Androstenedione Production Bases, Sales Regions and Major Competitors
Table Xi'an Gaoyuan Bio-Chem Androstenedione Product
Table Xi'an Gaoyuan Bio-Chem Androstenedione Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Xi'an Gaoyuan Bio-Chem Androstenedione Sales Market Share in 2017
Figure Global Xi'an Gaoyuan Bio-Chem Androstenedione Revenue Market Share in 2017
Table Dongyao Pharmaceutical
Table Dongyao Pharmaceutical Androstenedione
Table Huazhong Pharmaceutical
Table Huazhong Pharmaceutical Androstenedione
Table Darui
Table Darui Androstenedione
Table Danjiangkou Danao
Table Danjiangkou Danao Androstenedione
Table Dahua Pharmaceutical
Table Dahua Pharmaceutical Androstenedione
Table Global Androstenedione Sales by Manufacturer (2016-2017)
Figure Global Androstenedione Sales Market Share by Manufacturer in 2016
Figure Global Androstenedione Sales Market Share by Manufacturer in 2017
Table Global Androstenedione Revenue by Manufacturer (2016-2017)
Figure Global Androstenedione Revenue Market Share by Manufacturer in 2016
Figure Global Androstenedione Revenue Market Share by Manufacturer in 2017
Table Global Androstenedione Price by Manufacturer (2016-2017)
Figure Top 3 Androstenedione Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Androstenedione Manufacturer (Revenue) Market Share in 2017
Figure Global Androstenedione Sales and Growth Rate (2013-2018)
Figure Global Androstenedione Revenue and Growth Rate (2013-2018)
Table Global Androstenedione Sales by Regions (2013-2018)
Table Global Androstenedione Sales Market Share by Regions (2013-2018)
Table Global Androstenedione Revenue by Regions (2013-2018)
Figure Global Androstenedione Revenue Market Share by Regions in 2013
Figure Global Androstenedione Revenue Market Share by Regions in 2017
Figure North America Androstenedione Sales and Growth Rate (2013-2018)
Figure North America Androstenedione Revenue and Growth Rate (2013-2018)
Figure Europe Androstenedione Sales and Growth Rate (2013-2018)
Figure Europe Androstenedione Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Androstenedione Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Androstenedione Revenue and Growth Rate (2013-2018)
Figure South America Androstenedione Sales and Growth Rate (2013-2018)
Figure South America Androstenedione Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Androstenedione Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Androstenedione Revenue and Growth Rate (2013-2018)
Figure North America Androstenedione Revenue and Growth Rate (2013-2018)
Table North America Androstenedione Sales by Countries (2013-2018)
Table North America Androstenedione Sales Market Share by Countries (2013-2018)
Figure North America Androstenedione Sales Market Share by Countries in 2013
Figure North America Androstenedione Sales Market Share by Countries in 2017
Table North America Androstenedione Revenue by Countries (2013-2018)
Table North America Androstenedione Revenue Market Share by Countries (2013-2018)
Figure North America Androstenedione Revenue Market Share by Countries in 2013
Figure North America Androstenedione Revenue Market Share by Countries in 2017
Figure United States Androstenedione Sales and Growth Rate (2013-2018)
Figure Canada Androstenedione Sales and Growth Rate (2013-2018)
Figure Mexico Androstenedione Sales and Growth Rate (2013-2018)
Table North America Androstenedione Sales by Manufacturer (2016-2017)
Figure North America Androstenedione Sales Market Share by Manufacturer in 2016
Figure North America Androstenedione Sales Market Share by Manufacturer in 2017
Table North America Androstenedione Revenue by Manufacturer (2016-2017)
Figure North America Androstenedione Revenue Market Share by Manufacturer in 2016
Figure North America Androstenedione Revenue Market Share by Manufacturer in 2017
Table North America Androstenedione Sales by Type (2013-2018)
Table North America Androstenedione Sales Share by Type (2013-2018)
Table North America Androstenedione Revenue by Type (2013-2018)
Table North America Androstenedione Revenue Share by Type (2013-2018)
Table North America Androstenedione Sales by Application (2013-2018)
Table North America Androstenedione Sales Share by Application (2013-2018)
Table North America Androstenedione Revenue by Application (2013-2018)
Table North America Androstenedione Revenue Share by Application (2013-2018)
Figure Europe Androstenedione Revenue and Growth Rate (2013-2018)
Table Europe Androstenedione Sales by Countries (2013-2018)
Table Europe Androstenedione Sales Market Share by Countries (2013-2018)
Table Europe Androstenedione Revenue by Countries (2013-2018)
Figure Europe Androstenedione Revenue Market Share by Countries in 2016
Figure Europe Androstenedione Revenue Market Share by Countries in 2017
Figure Germany Androstenedione Sales and Growth Rate (2013-2018)
Figure UK Androstenedione Sales and Growth Rate (2013-2018)
Figure France Androstenedione Sales and Growth Rate (2013-2018)
Figure Russia Androstenedione Sales and Growth Rate (2013-2018)
Figure Italy Androstenedione Sales and Growth Rate (2013-2018)
Table Europe Androstenedione Sales by Manufacturer (2016-2017)
Figure Europe Androstenedione Sales Market Share by Manufacturer in 2016
Figure Europe Androstenedione Sales Market Share by Manufacturer in 2017
Table Europe Androstenedione Revenue by Manufacturer (2016-2017)
Figure Europe Androstenedione Revenue Market Share by Manufacturer in 2016
Figure Europe Androstenedione Revenue Market Share by Manufacturer in 2017
Table Europe Androstenedione Sales by Type (2013-2018)
Table Europe Androstenedione Sales Share by Type (2013-2018)
Table Europe Androstenedione Revenue by Type (2013-2018)
Table Europe Androstenedione Revenue Share by Type (2013-2018)
Table Europe Androstenedione Sales by Application (2013-2018)
Table Europe Androstenedione Sales Share by Application (2013-2018)
Table Europe Androstenedione Revenue by Application (2013-2018)
Table Europe Androstenedione Revenue Share by Application (2013-2018)
Figure Asia-Pacific Androstenedione Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Androstenedione Sales by Countries (2013-2018)
Table Asia-Pacific Androstenedione Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Androstenedione Sales Market Share by Countries 2017
Table Asia-Pacific Androstenedione Revenue by Countries (2013-2018)
Figure Asia-Pacific Androstenedione Revenue Market Share by Countries 2017
Figure China Androstenedione Sales and Growth Rate (2013-2018)
Figure Japan Androstenedione Sales and Growth Rate (2013-2018)
Figure Korea Androstenedione Sales and Growth Rate (2013-2018)
Figure India Androstenedione Sales and Growth Rate (2013-2018)
Figure Southeast Asia Androstenedione Sales and Growth Rate (2013-2018)
Table Asia-Pacific Androstenedione Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Androstenedione Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Androstenedione Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Androstenedione Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Androstenedione Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Androstenedione Revenue Market Share by Manufacturer in 2017
Tab
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Urinary Incontinence - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 86
    Urinary Incontinence - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Urinary Incontinence - Pipeline Review, H2 2018, provides an overview of the Urinary Incontinence (Genito Urinary System And Sex Hormones) pipeline landscape. Urinary incontinence is a loss of control of the bladder. In some cases, it may result in a total loss of the bladder's contents or it may just cause minor leakag......
  • Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 130
    Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018, provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) (Genito Urinary System And Sex Hormones) pipeline landscape. Acute kidney failure occurs when kidneys suddenly become unable to filter waste p......
  • Nocturia - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 33
    Nocturia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H2 2018, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape. Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of ......
  • Secondary Hyperparathyroidism - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 2000 Onwards        Pages: 38
    Secondary Hyperparathyroidism - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Secondary Hyperparathyroidism - Pipeline Review, H2 2018, provides an overview of the Secondary Hyperparathyroidism (Hormonal Disorders) pipeline landscape. Secondary hyperparathyroidism is occurs when the parathyroid glands in neck produce too much parathyroid hormone (PTH) because calcium levels are too low. ......
  • 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 32
    72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H2 2018 Summary 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) pipeline Target constitutes close to 7 molecules. Out of which approximately 4 molecules are developed by companies and remaining by the ......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs